Author name: druganddevicedigest

Clin. Pharm. Card: INTRAROSA

December 19, 2016December 21, 2016 Drug & Device Advisory Group Other Clin. Pharm. Card: INTRAROSA INTRAROSA (prasterone) vaginal inserts  INDICATION: Steroid indicated for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause.  Mechanism of Action Prasterone is an inactive endogenous steroid and is converted into active androgens …

Clin. Pharm. Card: INTRAROSA Read More »

Best Practices: FDA and IND Sponsor Communications

February 3, 2017 Drug & Device Advisory Group Link and Learn Best Practices: FDA and IND Sponsor Communications Philosophy on Timely Interactive Communication Scope of Appropriate Interactions Types of Advice Expectations for Response Timing Best Practices and Communication Methods LEARN Share this: Email Print WhatsApp Like this: Like Loading… Published by Drug & Device Advisory …

Best Practices: FDA and IND Sponsor Communications Read More »

News and Views: Coronavirus medical countermeasures, 2019 New Therapies, Gene Therapy innovation, Deter anti-competitive business for biologics, Heart Health education for women, HIV Drugs mobile database, Warning for nicotine toothpicks – Drug and Device Digest

Advance Development of Novel Coronavirus Medical Countermeasures (MCM) FDA collaborating with interagency partners, product developers, international partners and global regulators to Expedite development and availability of MCM to diagnose, treat, mitigate, prevent Utilize pathways, including Emergency Use Authorization (EUA) to more rapidly make MCM available Provide regulatory advice, guidance, and technical assistance to  sponsors developing …

News and Views: Coronavirus medical countermeasures, 2019 New Therapies, Gene Therapy innovation, Deter anti-competitive business for biologics, Heart Health education for women, HIV Drugs mobile database, Warning for nicotine toothpicks – Drug and Device Digest Read More »

Market Authorizations: 2019-nCoV diagnostic, ERVEBO Ebola vaccine, TEPEZZA for thyroid eye disease

February 10, 2020 Drug & Device Advisory Group FDA Briefs Market Authorizations: 2019-nCoV diagnostic, ERVEBO Ebola vaccine, TEPEZZA for thyroid eye disease 2019-nCoV Real-Time RT-PCR Diagnostic Panel CDC INTENDED USE: For the presumptive qualitative detection of nucleic acid from the 2019-nCoV in upper and lower respiratory specimens (such as nasopharyngeal or oropharyngeal swabs, sputum, lower …

Market Authorizations: 2019-nCoV diagnostic, ERVEBO Ebola vaccine, TEPEZZA for thyroid eye disease Read More »

Clinical Trial of Remdesivir to Treat COVID-19

February 26, 2020 Drug & Device Advisory Group Link and Learn Clinical Trial of Remdesivir to Treat COVID-19 NIH (NIAID) Clinical Trial of Remdesivir to Treat COVID-19 Begins Randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral REMDESIVIR in hospitalized adults diagnosed with COVID-19  Remdesivir is an investigational broad-spectrum antiviral …

Clinical Trial of Remdesivir to Treat COVID-19 Read More »

May 2021

Month: May 2021 May 2, 2021 Drug & Device Advisory Group FDA Briefs News and Views: Janssen COVID vaccine pause lifted, Guidance for developing COVID drugs, New pharmacometrics approach, Standards to ban menthol cigarettes, CDRH patient science, Opioid safe disposal, Colorectal cancer screening FDA and CDC Lift Recommended Pause on Janssen Vaccine Use Following Thorough …

May 2021 Read More »

FDA Division of Biology, Chemistry, and Materials Science

September 19, 2016 Drug & Device Advisory Group Link and Learn FDA Division of Biology, Chemistry, and Materials Science WHAT: Part of  Office of Science and Engineering Laboratories (OSEL), CDRH WHY: Determine effects of implanted devices, potential device adverse effects,  source and impact of device degradation Develop experimental data, test methods, and protocols Develop measurements, …

FDA Division of Biology, Chemistry, and Materials Science Read More »

Habitual chocolate consumption could reduce the risk of cardiovascular disease

June 22, 2015 Drug & Device Advisory Group Other Habitual chocolate consumption could reduce the risk of cardiovascular disease Authors in a study examined the association between chocolate intake and the risk of future cardiovascular events in total of 20951 men and women. Authors evaluated chocolate consumption and cardiovascular outcomes. Results suggested that higher chocolate …

Habitual chocolate consumption could reduce the risk of cardiovascular disease Read More »

Scroll to Top